Navigating Biotech: Past, Present, and Future

This chapter examines the interplay between medical advancements, entertainment in the economy, and historical contexts of genetic engineering, including species like woolly mammoths. It highlights the evolution of biotechnology investments and public markets, emphasizing recent successful developments like the public offering of a biotech firm under the ticker DNA. Additionally, the discussion addresses transparency and trust in genetically modified organisms (GMOs) and the necessity for consumer education to foster acceptance of innovative solutions in sustainability.